-+ 0.00%
-+ 0.00%
-+ 0.00%

Protara Therapeutics Q4 net loss widens 35% to USD 17.31 million as R&D spending rises 38% to USD 13.12 million

Reuters·03/10/2026 12:05:55

Please log in to view news